MULTICENTER EVALUATION OF MEMORY REMEDIATION AFTER TRAUMATIC BRAIN INJURYWITH DONEPEZIL: THE MEMRI-TBI-D STUDY
Flora Hammond, MD
Primary Investigator
Jessica MacLean
Primary Investigator
Brief description of study
The purpose of this study is to determine whether donepezil is an effective treatment for memory problems among adults who experienced traumatic brain injury 6-35 months ago.
Detailed description of study
This study is a four-site, randomized, parallel design, double-blind, placebo-controlled, 10-week trial that will evaluate the effect of donepezil on treatment for functionally important verbal memory problems among 160 individuals (age 18-60 years) who sustained a complicated mild, moderate, or severe non-penetrating TBI six to 36 months prior to study participation.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: traumatic brain injury
-
Age: 18 years - 60 years
-
Gender: All